For example, among postmenopausal nonusers of hormone therapy, women who were classified in the highest versus lowest quartile of insulin levels had a 2.3-fold increased risk of developing endometrioid-type endometrial cancer [21]. The gene discussed is INS; the disease is endometrial cancer.